Mangrove Partners’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Mangrove Partners’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,779,448	Closed	-$5.93M	–	82
2019 Q4	$5.93M	Buy	+1,779,448	New	+$5.66M	0.87%	26

Mangrove Partners's FOMX Position: Q1 2020 in Review

Mangrove Partners sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 1,779,448 shares — an estimated $5.93M sold.

Mangrove Partners first reported a position in FOMX in Q4 2019 and held it in 1 quarter. The position peaked at $5.93M in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Mangrove Partners reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Mangrove Partners sold 1,779,448 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $5.93M.
Mangrove Partners first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2019 and held it in 1 quarter.
Mangrove Partners's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $5.93M in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Mangrove Partners's 13F filing for Q1 2020, filed 15 May 2020.